# Statin Effect on Arrhythmogenic Cardiomyopathy Disease Progression (SEARCH)

> **NCT06922994** · PHASE2 · RECRUITING · sponsor: **Centro Cardiologico Monzino** · enrollment: 102 (estimated)

## Conditions studied

- Arrhythmogenic Cardiomyopathy

## Interventions

- **DRUG:** Atorvastatin 80 mg/day
- **DRUG:** Placebo atorvastatin

## Key facts

- **NCT ID:** NCT06922994
- **Lead sponsor:** Centro Cardiologico Monzino
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-31
- **Primary completion:** 2026-11-30
- **Final completion:** 2026-11-30
- **Target enrollment:** 102 (ESTIMATED)
- **Last updated:** 2025-07-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06922994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06922994, "Statin Effect on Arrhythmogenic Cardiomyopathy Disease Progression (SEARCH)". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT06922994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*